These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8734355)

  • 1. Progress and challenges toward an AIDS vaccine: Brother, can you spare a paradigm?
    Koff WC; Schultz AM
    J Clin Immunol; 1996 May; 16(3):127-33. PubMed ID: 8734355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonhuman primate models for HIV vaccine development.
    Letvin NL
    Immunodefic Rev; 1992; 3(3):247-60. PubMed ID: 1510838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Present status of vaccination against HIV-1 infection.
    Girard M
    Int J Immunopharmacol; 1995 Feb; 17(2):75-8. PubMed ID: 7657409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and testing of AIDS vaccines.
    Koff WC; Hoth DF
    Science; 1988 Jul; 241(4864):426-32. PubMed ID: 3293212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of an AIDS vaccine: progress and promise.
    Fauci AS; Fischinger PJ
    Public Health Rep; 1988; 103(3):230-6. PubMed ID: 3131812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards an HIV-1 vaccine: lessons from studies in macaque models.
    Hulskotte EG; Geretti AM; Osterhaus AD
    Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.
    García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates.
    Le Grand R; Dereuddre-Bosquet N; Dispinseri S; Gosse L; Desjardins D; Shen X; Tolazzi M; Ochsenbauer C; Saidi H; Tomaras G; Prague M; Barnett SW; Thiebaut R; Cope A; Scarlatti G; Shattock RJ
    J Virol; 2016 Jun; 90(11):5315-5328. PubMed ID: 27009957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the search for an HIV vaccine.
    Lemckert AA; Goudsmit J; Barouch DH
    Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress toward an HIV vaccine.
    Letvin NL
    Annu Rev Med; 2005; 56():213-23. PubMed ID: 15660510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS: is there an answer to the global pandemic? The immune system in HIV infection and control.
    Maplanka C
    Viral Immunol; 2007 Sep; 20(3):331-42. PubMed ID: 17931104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Designing an effective AIDS vaccine: strategies and current status].
    Coutsinos Z; Absi Z; Henin Y; Guillet JG; Launay O
    Rev Med Interne; 2008 Aug; 29(8):632-41. PubMed ID: 18258341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide survey of AIDS vaccine challenge studies in nonhuman primates: vaccines associated with active and passive immune protection from live virus challenge.
    Warren JT; Dolatshahi M
    J Med Primatol; 1992; 21(2-3):139-86. PubMed ID: 1433265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An attenuated vaccine for AIDS?
    Beale J
    Lancet; 1995 May; 345(8961):1318-9. PubMed ID: 7752750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.
    Cafaro A; Macchia I; Maggiorella MT; Titti F; Ensoli B
    Adv Exp Med Biol; 2009; 655():189-242. PubMed ID: 20047043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS vaccines for Africa: scientific opportunities, challenges and strategies.
    Chin'ombe N; Ruhanya V
    Pan Afr Med J; 2015; 20():386. PubMed ID: 26185576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for an AIDS vaccine: three big questions, no easy answers.
    Garber DA; Silvestri G; Feinberg MB
    Lancet Infect Dis; 2004 Jul; 4(7):397-413. PubMed ID: 15219551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.